https://www.kolinpharma.com/ https://www.kolinpharma.com/01-kolinpharma https://www.kolinpharma.com/03-tutela-consumatore https://www.kolinpharma.com/02-ricerca-sviluppo https://www.kolinpharma.com/04-partners https://www.kolinpharma.com/05-ambiente https://www.kolinpharma.com/06-pmi-innovativa https://www.kolinpharma.com/07-nutraceutica https://www.kolinpharma.com/08-mission https://www.kolinpharma.com/09-organizzazione-aziendale https://www.kolinpharma.com/10-certificazioni https://www.kolinpharma.com/11-corporate-compliance https://www.kolinpharma.com/12-certificazioni-prodotto https://www.kolinpharma.com/13-prodotti https://www.kolinpharma.com/14-almetax-sk https://www.kolinpharma.com/15-dolatrox-sk https://www.kolinpharma.com/16-ivuxur-sk https://www.kolinpharma.com/17-milesax-sk https://www.kolinpharma.com/18-xinepa-sk https://www.kolinpharma.com/21-news-archivio https://www.kolinpharma.com/22-dove-siamo https://www.kolinpharma.com/23-lavora-con-noi https://www.kolinpharma.com/24-privacy-it https://www.kolinpharma.com/25-contatti-feedback-it https://www.kolinpharma.com/26-info-consumatori https://www.kolinpharma.com/27-info-medici https://www.kolinpharma.com/28-info-farmacie https://www.kolinpharma.com/29-info-generica https://www.kolinpharma.com/30-codice-etico-e-modello-organizzativo-231 https://www.kolinpharma.com/32-note-legali https://www.kolinpharma.com/33-materie-prime https://www.kolinpharma.com/34-intolleranze-alimentari https://www.kolinpharma.com/35-confezioni https://www.kolinpharma.com/36-informazioni-braille https://www.kolinpharma.com/37-tamper-evident https://www.kolinpharma.com/38-conservazione-trasporto https://www.kolinpharma.com/39-modulo-nutraceutico https://www.kolinpharma.com/40-investor-relations https://www.kolinpharma.com/42-xinepa-easy-sk https://www.kolinpharma.com/43-almetax-easy-sk https://www.kolinpharma.com/44-highlights https://www.kolinpharma.com/45-info-investitori https://www.kolinpharma.com/46-contatti-media-relations https://www.kolinpharma.com/47-press-kit https://www.kolinpharma.com/48-governance https://www.kolinpharma.com/49-documenti https://www.kolinpharma.com/50-organi-sociali https://www.kolinpharma.com/51-ipo https://www.kolinpharma.com/52-info-azionisti https://www.kolinpharma.com/53-investor-news https://www.kolinpharma.com/54-news-investor-archivio https://www.kolinpharma.com/almetax-easy-foglietto https://www.kolinpharma.com/almetax-foglietto https://www.kolinpharma.com/dolatrox-foglietto https://www.kolinpharma.com/ivuxur-foglietto https://www.kolinpharma.com/milesax-foglietto https://www.kolinpharma.com/xinepa-easy-foglietto https://www.kolinpharma.com/xinepa-foglietto https://www.kolinpharma.com/it/news/kolinpharma-ottenuto-il-riconoscimento-leader-della-crescita-2025 https://www.kolinpharma.com/it/news/kolinpharma-inserita-tra-le-100-eccellenze-italiane https://www.kolinpharma.com/it/news/kolinpharma%AE--nuovo-brevetto-in-cina-per-doltendix%AE https://www.kolinpharma.com/it/news/kolinpharma%AE--ricevuto-il-premio-credit-reputation-award-2023 https://www.kolinpharma.com/it/news/kolinpharma%AE-amplia-il-portafoglio-prodotti-con-il-lancio-di-kymax%AE https://www.kolinpharma.com/it/news/kolinpharma--per-la-prima-volta-nella-storia-dell-azienda-il-debutto-di-un-prodotto-gia-brevettato https://www.kolinpharma.com/it/news/kolinpharma%AE-presenta-il-nuovo-kipfer%AE https://www.kolinpharma.com/it/news/kolinpharma-e-lieta-di-annunciare-il-lancio-di-kipfer%AE--a-base-di-idrossido-di-ferro-adipato-tartrato-ihat%99--fonte-di-ferro-innovativa--sicura-ed-efficace https://www.kolinpharma.com/it/news/kolinpharma-declinex https://www.kolinpharma.com/it/news/kolinpharma-lancia-declinex https://www.kolinpharma.com/it/news/kolinpharma-per-la-parita-di-genere-a-pmiheroes https://www.kolinpharma.com/it/news/kolinpharma-si-aggiudica-i-cr-awards-di-milano-finanza https://www.kolinpharma.com/it/news/kolinpharma-ottenuto-il-primo-brevetto-per-xinprox https://www.kolinpharma.com/it/news/kolinpharma%AE--ottenuto-il-riconoscimento-leader-della-crescita-2023-per-il-quinto-anno-consecutivo https://www.kolinpharma.com/it/news/l-accordo-tra-kolinpharma-e-astrareal-sulle-piu-importanti-testate-finanziarie https://www.kolinpharma.com/it/news/kolinpharma-sottoscrive-un-accordo-con-astareal-ab-per-la-distribuzione-dei-prodotti-nel-mercato-orientale https://www.kolinpharma.com/it/news/su-milano-finanza-l-accordo-di-distribuzione-tra-kolinpharma%3Csup%3E%AE%3C-sup%3E-e-astareal%3Csup%3E%AE%3C-sup%3E https://www.kolinpharma.com/it/news/kolinpharma-bilancio-di-sostenibilita-2021 https://www.kolinpharma.com/it/news/kolinpharma-riceve-il-premio-industria-felix https://www.kolinpharma.com/it/news/kolinpharma-scala-il-ranking-annuale https://www.kolinpharma.com/it/news/envent-winter-conference-2022 https://www.kolinpharma.com/it/news/kolinpharma%AE-ottiene-il-primo-brevetto-per-doltendix%AE https://www.kolinpharma.com/it/news/kolinpharma-3-nuovi-brevetti-in-europa-e-usa--salgono-cosi-a-44-i-brevetti-totali https://www.kolinpharma.com/it/news/rita-paola-petrelli-ospite-alla-trasmissione-sanita-next--canale-class-cnbc https://www.kolinpharma.com/it/news/kolinpharma-leader-della-crescita-2022 https://www.kolinpharma.com/it/news/cuore-economico-intervista-rita-paola-petrelli https://www.kolinpharma.com/it/news/kolinpharma-su-borsa-italiana https://www.kolinpharma.com/it/news/ir-top-lugano-investor-day-169 https://www.kolinpharma.com/it/news/kolinpharma%AE-lancia-il-progetto-di-formazione-kip-academy%94 https://www.kolinpharma.com/it/news/kolinpharma%AE-annuncia-il-lancio-dell-e-commerce https://www.kolinpharma.com/it/news/kolinpharma%AE-brilla-sull-aim-dopo-il-lancio-di-xinprox-e-l-annuncio-della-filiale-svizzera https://www.kolinpharma.com/it/news/kolinpharma-al-vitafoods-europe-2021-di-ginevra-e-al-cphi-worldwide-2021-di-milano https://www.kolinpharma.com/it/news/rita-paola-petrelli-su-forbes-164 https://www.kolinpharma.com/it/news/rita-paola-petrelli-su-forbes https://www.kolinpharma.com/it/news/kolinpharma-nello-speciale-de-il-sole-24-ore-industria-nutraceutica---realta-eccellenti%94 https://www.kolinpharma.com/it/news/aim-italia-conference-di-borsa-italiana https://www.kolinpharma.com/it/news/quotazione-in-borsa-per-le-pmi--vetrina-per-le-eccellenze-del-centro-sud-italia https://www.kolinpharma.com/it/news/aim-retail-investor-day https://www.kolinpharma.com/it/news/kolinpharma-su-bfc-finanza-operativa https://www.kolinpharma.com/it/news/kolinpharma-classificata-al-primo-posto-sul-tema-capitale-umano-nel-primo-esg-report-dedicato-al-mercato-azionario-italiano https://www.kolinpharma.com/it/news/green-sustainable-investor-day https://www.kolinpharma.com/it/news/l-innovazione-del-modello-di-business-di-kolinpharma--un-metodo-di-ricerca-farmaceutica-applicato-alla-nutraceutica https://www.kolinpharma.com/it/news/per-il-terzo-anno-consecutivo-kolinpharma-e-nella-classifica-ft1000---europe-s-fastest-growing-companies-del-financial-times-e-di-statista https://www.kolinpharma.com/it/news/kolinpharma--mecar--smartegreen-mobility-service-provider--sceglie-kip-kit-per-il-welfare-aziendale https://www.kolinpharma.com/it/news/kolinpharma-rafforza-la-strategia-di-welfare-aziendale https://www.kolinpharma.com/it/news/kolinpharma-sul-report-di-dicembre-2020-luiss-business-school-e-il-sole-24-ore-radiocor https://www.kolinpharma.com/it/news/kolinpharma--primo-brevetto-per-miledix-salgono-a-5-i-brevetti-in-italia https://www.kolinpharma.com/it/news/kolinpharma%AE-leader-della-crescita-2021per-il-terzo-anno-consecutivo https://www.kolinpharma.com/it/news/rita-paola-petrelli-su-blastingnews https://www.kolinpharma.com/it/news/kolinpharma-su-il-sole-24-ore-plus-146 https://www.kolinpharma.com/it/news/kolinpharma-nuova-concessione-di-brevetto-per-milesax https://www.kolinpharma.com/it/news/aim-investor-day-2020-144 https://www.kolinpharma.com/it/news/kolinpharma-lancia-ivuxur-compresse https://www.kolinpharma.com/it/news/kolinpharma-su-repubblica-141 https://www.kolinpharma.com/it/news/kolinpharma-su-thinkit https://www.kolinpharma.com/it/news/kolinpharma-su-il-sole-24-ore-luglio-2020 https://www.kolinpharma.com/it/news/kolinpharma-su-il-sole-24-ore-plus24 https://www.kolinpharma.com/it/news/aim-investor-day-2020 https://www.kolinpharma.com/it/news/kolinpharma-su-class-cnbc https://www.kolinpharma.com/it/news/una-forte-espansione-sul-mercato-europeo https://www.kolinpharma.com/it/news/kolinpharma%AE-a-class-cnbc-per-parlare-di-sviluppo-del-mercato--bilancio-di-sostenibilita---esg--brevetti-ed-internalizzazione-della-rete-vendita https://www.kolinpharma.com/it/news/l-assemblea-approva-il-bilancio-2019-di-kolinpharma-e-rinnova-la-governance https://www.kolinpharma.com/it/news/kolinpharma%AE-a-pmi-capital-con-l-approvazione-del-bilancio-2019 https://www.kolinpharma.com/it/news/kolinpharma%AE--primo-brevetto-per-xinepa-in-israele-e-quinto-fuori-dall-italia https://www.kolinpharma.com/it/news/per-il-secondo-anno-kolinpharma-sul-ft1000---europe-s-fastest-growing-companies https://www.kolinpharma.com/it/news/kolinpharma-dona-un-ventilatore-polmonare-alla-citta-di-catanzaro https://www.kolinpharma.com/it/news/kolinpharma--prosegue-l-attivita--aziendale https://www.kolinpharma.com/it/news/kolinpharma%AE-a-pmi-capital-%96-speciale-covid19 https://www.kolinpharma.com/it/news/kolinpharma--su-aimnews-con-il-quarto-brevetto-usa https://www.kolinpharma.com/it/news/brevetto-usa-per-dolatrox https://www.kolinpharma.com/it/news/kolinpharma%3Csup%3E%AE%3C-sup%3E-ottiene-il-brevetto-in-usa-di-dolatrox%3Csup%3E%AE%3C-sup%3E https://www.kolinpharma.com/it/news/kolinpharma-nel-salotto-di-italiastartup https://www.kolinpharma.com/it/news/aim-news-e-l-intervista-a-rita-paola-petrelli https://www.kolinpharma.com/it/news/per-il-secondo-anno-kolinpharma-tra-i-leader-della-crescita https://www.kolinpharma.com/it/news/kolinpharma%AE-al-tgr-lombardia https://www.kolinpharma.com/it/news/aim-investor-day-2019 https://www.kolinpharma.com/it/news/kolinpharma-uni-iso-37001 https://www.kolinpharma.com/it/news/kolinpharma-al-convegno-di-varese-su-mercati-azionari-e-capitale-per-le-imprese https://www.kolinpharma.com/it/news/kolinpharma%AE-convegno-disfunzioni-pelviperineali-pavia https://www.kolinpharma.com/it/news/petrelli-ministero-innovazione https://www.kolinpharma.com/it/news/un-modello-di-business-che-guarda-oltre https://www.kolinpharma.com/it/news/brevetto-usa-per-ivuxur https://www.kolinpharma.com/it/news/kolinpharma%AE-ottiene-il-brevetto-in-usa-per-il-prodotto-xinepa%AE--e-il-titolo-festeggia https://www.kolinpharma.com/it/news/kiptogo-kolinpharma-per-il-sociale https://www.kolinpharma.com/it/news/kolinpharma-investe-in-qualita-e-sicurezza-dei-prodotti https://www.kolinpharma.com/it/news/kolinpharma-al-4-corso-itinerante-sotimi https://www.kolinpharma.com/it/news/intervista-finanza-operativa https://www.kolinpharma.com/it/news/kolinpharma-partecipa-al-progetto-new-tourpmi https://www.kolinpharma.com/it/news/aimnewsit-intervista-rita-paola-petrelli https://www.kolinpharma.com/it/news/kolinpharma-al-congresso-di-modena-sui-disturbi-della-riproduzione https://www.kolinpharma.com/it/news/ft1000-2019-europe-s-fastest-growing-companies https://www.kolinpharma.com/it/news/kolinpharma-piu-vicina-ai-consumatori-con-i-siti-di-prodotto https://www.kolinpharma.com/it/news/la-ricerca-kolinpharma-anticipa-i-tempi https://www.kolinpharma.com/it/news/kolinpharma--modello-vincente-nel-business-della-nutraceutica https://www.kolinpharma.com/it/news/kolinpharma-e-l-universita-la-sapienza%94-di-roma-formano-i-manager-del-futuro https://www.kolinpharma.com/it/news/aim-investor-day https://www.kolinpharma.com/it/news/kolinpharma-raddoppio-fatturato-fine-2018 https://www.kolinpharma.com/it/news/asi-siot2018-osteoartrosi https://www.kolinpharma.com/it/news/ilsole24ore-intervista-rita-paola-petrelli-emanuele-lusenti https://www.kolinpharma.com/it/news/kolinpharma-leader-crescita-2019 https://www.kolinpharma.com/it/news/ir-top-lugano-investor-day https://www.kolinpharma.com/it/news/borsa-italiana-intervista-petrelli-lusenti https://www.kolinpharma.com/it/news/osservatorio-aim-italia--cresce-la-quotazione-kolinpharma https://www.kolinpharma.com/it/news/intervista-rita-paola-petrelli-teleborsa https://www.kolinpharma.com/it/news/osservatorio-ir-top-su-aim-italia https://www.kolinpharma.com/it/news/milesax-progetto-finalista https://www.kolinpharma.com/it/news/la-borsa-e-attraente-per-le-piccole-di-valore https://www.kolinpharma.com/it/news/aim-italia-conference-2018--milan https://www.kolinpharma.com/it/news/in-crescita-le-prescrizioni-mediche-2018 https://www.kolinpharma.com/it/news/kolinpharma-e-outperform-per-envent--target-a-8-54-euro https://www.kolinpharma.com/it/news/bonus-quotazione--il-decreto-attuativo-sul-credito-di-imposta https://www.kolinpharma.com/it/news/accompagnare-le-pmi-alla-quotazione-su-aim---borsa-italiana https://www.kolinpharma.com/it/news/kolinpharma--per-ir-top-research-vale-8-67-per-azione https://www.kolinpharma.com/it/news/kolinpharma--forte-crescita-per-la-%ABsmall-pharma%BB-dell-aim https://www.kolinpharma.com/it/news/brief-kolinpharma-fy-production-value-up-at-eur-53-mln https://www.kolinpharma.com/it/news/kolipharma--lusenti--mercato-nutraceutica-vale-3-mld-in-italia https://www.kolinpharma.com/it/news/kolinpharma--nel-2017-perdite-in-calo-%80-0-07-mln https://www.kolinpharma.com/it/news/kolinpharma-chiude-un-2017-in-forte-espansione https://www.kolinpharma.com/it/news/kolinpharma--ricavi-vendite-2017-a-4-1-mln https://www.kolinpharma.com/it/news/kolinpharma--nel-2017-62-i-ricavi-e-130-ebitda https://www.kolinpharma.com/it/news/kolinpharma--i-conti-del-2017 https://www.kolinpharma.com/it/news/kolinpharma--risultati-dello-studio-su-integratore-alimentare-xinepa https://www.kolinpharma.com/it/news/kolinpharma--xinepa-e-efficace-per-le-neuropatie-periferiche https://www.kolinpharma.com/it/news/kolinpharma--confermata-l-efficacia-clinica-dello-xinepa https://www.kolinpharma.com/it/news/kolinpharma-vola-grazie-all-integratore-xinepa https://www.kolinpharma.com/it/news/kolinpharma--titolo-avanza-di-oltre-il-5-sull-aim-post-risultati-su-integratore-xinepa https://www.kolinpharma.com/it/news/kolinpharma-e-gia-la-quinta-matricola-in-borsa-dell-anno https://www.kolinpharma.com/it/news/kolinpharma-debutta-oggi-su-aim-italia https://www.kolinpharma.com/it/news/kolinpharma--primo-giorno-di-quotazione-su-aim-italia https://www.kolinpharma.com/it/news/kolinpharma-su-milano-finanza https://www.kolinpharma.com/it/news/borsa--kolinpharma-sbarca-su-aim https://www.kolinpharma.com/it/news/debutto-in-sordina-per-kolinpharma-nutraceutica-sotto-il-collocamento https://www.kolinpharma.com/it/news/kolinpharma--debutto-in-retromarcia-a-piazza-affari https://www.kolinpharma.com/it/news/ipo-2018-piazza-affari--kolinpharma-sbarca-su-aim-italia https://www.kolinpharma.com/it/news/kolinpharma-al-debutto-in-borsa-il-9-marzo-2018 https://www.kolinpharma.com/it/news/kolinpharma-sbarca-su-borsa-italiana--quotazione-al-via-domani https://www.kolinpharma.com/it/news/Kolinpharma-al-debutto-in-Borsa-il-9-marzo https://www.kolinpharma.com/it/news/kolinpharma--domani-debuttera-sul-listino-aim-italia--prezzo-fissato-a-7-euro https://www.kolinpharma.com/it/news/kolinpharma-in-borsa-il-9-marzo-con-envent https://www.kolinpharma.com/it/news/kolinpharma-al-debutto-sull-aim https://www.kolinpharma.com/it/news/rinnovate-le-certificazioni-da-parte-di-bureau-veritas https://www.kolinpharma.com/it/news/l-informazione-medica-scientifica--un-lavoro-straordinario--perche-etico--scientifico-e-in-empatia-col-medico https://www.kolinpharma.com/it/news/la-crescita-funzionale--la-politica-del-internal-growth https://www.kolinpharma.com/it/news/il-marketing--una-scienza-precisa-che-studia-il-mercato https://www.kolinpharma.com/it/news/l-attenzione-alle-forme-farmaceutice-per-una-piu-facile-compliance-del-paziente https://www.kolinpharma.com/it/news/la-kolinpharma-nella-ricerca-europea https://www.kolinpharma.com/it/news/un-qr-code-che-si-fa-vedere-da-chi-non-vede https://www.kolinpharma.com/it/news/il-tamper-evident-degli-astucci--tecnologia-brevettata-in-continua-evoluzione https://www.kolinpharma.com/it/news/kolinpharma-sceglie-hoffmann-e-eitle-italia-come-partner https://www.kolinpharma.com/it/news/una-societa-quotata-all-aim--come-depositario-e-logistica--bomi-group https://www.kolinpharma.com/it/news/il-team-di-ricerca-e-sviluppo-res--efficacia-e-innovazione https://www.kolinpharma.com/it/news/la-231-un-modello-che-ci-impegna-quotidianamente https://www.kolinpharma.com/it/news/materia-prima--una-ricerca-costante-all-eccellenza https://www.kolinpharma.com/it/news/2016--il-fatturato-kolinpharma-raddoppia https://www.kolinpharma.com/it/news/confermate-tutte-le-nostre-certificazioni https://www.kolinpharma.com/it/news/certificazione-doping-free--qualita--ed-etica https://www.kolinpharma.com/41-mod-page-investors?id=1 https://www.kolinpharma.com/41-mod-page-investors?id=2 https://www.kolinpharma.com/41-mod-page-investors?id=3 https://www.kolinpharma.com/41-mod-page-investors?id=4 https://www.kolinpharma.com/41-mod-page-investors?id=5 https://www.kolinpharma.com/41-mod-page-investors?id=11 https://www.kolinpharma.com/41-mod-page-investors?id=19